Skip to main content
News Icon

Honors & Funding

Cluster member among highly cited researcher

Annually the 'Highly Cited Researchers' are being announced by the 'Web of Science Group'.

At the University of Bonn 12 highly cited researcher are namend, among them are 6 members of the cluster of excellence ImmunoSensation.

According to the makers of the ranking, the people on this list of "Highly Cited Researchers" are among the most influential one percent of their subject. The measurement here is the frequency with which their scientific publications have been cited by other researchers in the past decade (period from 2008 to 2018). The ranking is published annually by the "Web of Science Group" and contains around 6,200 scientists in 21 subject categories.

Following members of ImmunoSensation2 are named 'Highly Cited Researcher':

Monique M. B. Breteler

Michael T. Heneka

Eicke Latz

Mihai G. Netea

Joachim L. Schultze

Andreas Schlitzer

Related news

Plastic bottles

Honors & Funding

Effects of “Forever Chemicals” on the Immune System

—Dr. Lorenzo Bonaguro from the German Center of Neurodegenerative Dieseases (DZNE) has been awarded a Starting Grant from the European Research Council (ERC) totaling about 1.5 million euros to investigate the influence of the ubiquitous PFAS chemicals on the immune system. His research will utilize so-called organoids and cutting-edge analysis methods.
View entry
Csm Bradke header 498bf3128b

Honors & Funding

Berlin-Brandenburg Academy of Science Honors Bonn Neurobiologist

—Neurobiologist Frank Bradke, a research group leader at DZNE and professor at the University of Bonn, has been awarded the 50,000 euro Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities. The award recognizes his outstanding scientific accomplishments in the field of neuronal development and regeneration. With his studies, the Bonn scientist, who focuses on fundamental mechanisms, aims to pave the way for a better treatment of spinal cord injuries. In recent years, Bradke has already been recognized with several awards for his exceptional research.
View entry
Hoerauf Huebner PM

Honors & Funding

Award for Drug Research on River Blindness and Elephantiasis

—The A∙WOL team has been awarded the Horizon Prize 2024 by the Royal Society of Chemistry for the discovery of potentially fast-acting, highly specific anti-Wolbachia candidates for the oral treatment of human filariasis. The team is a collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, Imperial College London, the University Hospital Bonn (UKB), and the University of Bonn, as well as industry partners AstraZeneca and Eisai Ltd, funded for many years by the Gates Foundation.
View entry

Back to the news overview